HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Ling Hsu Selected Research

rugosin E

4/2007Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ya-Ling Hsu Research Topics

Disease

69Neoplasms (Cancer)
07/2022 - 11/2004
29Lung Neoplasms (Lung Cancer)
05/2022 - 07/2004
26Breast Neoplasms (Breast Cancer)
01/2021 - 04/2005
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2018 - 07/2004
16Neoplasm Metastasis (Metastasis)
05/2022 - 04/2010
13Asthma (Bronchial Asthma)
12/2021 - 04/2011
8Inflammation (Inflammations)
12/2021 - 04/2005
7Adenocarcinoma of Lung
05/2022 - 08/2015
7Adenocarcinoma
01/2014 - 03/2005
6Carcinogenesis
12/2021 - 03/2004
6Liver Neoplasms (Liver Cancer)
12/2010 - 03/2004
5Airway Remodeling
11/2015 - 04/2011
4Hypoxia (Hypoxemia)
04/2021 - 09/2017
4Urinary Bladder Neoplasms (Bladder Cancer)
12/2011 - 10/2007
4Hepatocellular Carcinoma (Hepatoma)
05/2009 - 09/2004
3Chronic Renal Insufficiency
01/2021 - 01/2017
3Bone Resorption
05/2015 - 06/2013
2Nasopharyngeal Carcinoma
07/2022 - 05/2022
2Melanoma (Melanoma, Malignant)
10/2021 - 01/2008
2Carcinoma (Carcinomatosis)
01/2021 - 07/2009
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2018
2Cognitive Dysfunction
01/2020 - 02/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 06/2017
2Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 11/2015
2Colonic Neoplasms (Colon Cancer)
08/2018 - 01/2013
2Renal Cell Carcinoma (Grawitz Tumor)
08/2018 - 12/2017
2Hypersensitivity (Allergy)
02/2018 - 04/2010
2Water Intoxication
01/2018 - 01/2017
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 07/2017
2Lewis Lung Carcinoma
06/2017 - 06/2013
2Endometriosis
03/2016 - 02/2014

Drug/Important Bio-Agent (IBA)

15MicroRNAs (MicroRNA)IBA
10/2021 - 06/2013
12Proteins (Proteins, Gene)FDA Link
09/2021 - 04/2005
12FlavonoidsIBA
03/2016 - 03/2004
9Antineoplastic Agents (Antineoplastics)IBA
01/2014 - 10/2004
8Biomarkers (Surrogate Marker)IBA
05/2022 - 06/2017
8CytokinesIBA
02/2018 - 05/2009
7Pharmaceutical PreparationsIBA
05/2022 - 04/2007
7Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 08/2007
7Fas Ligand Protein (Fas Ligand)IBA
07/2010 - 09/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 07/2007
6Small Interfering RNA (siRNA)IBA
09/2020 - 04/2005
6Conditioned Culture MediaIBA
02/2016 - 08/2011
6NF-kappa B (NF-kB)IBA
12/2012 - 09/2004
5Biological ProductsIBA
06/2021 - 04/2010
5Interleukin-8 (Interleukin 8)IBA
12/2014 - 04/2010
4RNA (Ribonucleic Acid)IBA
05/2022 - 01/2020
4leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
12/2021 - 04/2016
4LigandsIBA
01/2021 - 11/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 07/2007
4Phosphotransferases (Kinase)IBA
02/2020 - 06/2008
4Estrogen ReceptorsIBA
02/2018 - 02/2014
4ChemokinesIBA
02/2018 - 04/2010
4Galectin 1 (LGALS1)IBA
05/2016 - 02/2011
3Uremic ToxinsIBA
01/2021 - 02/2019
3Cadherins (E-Cadherin)IBA
02/2018 - 01/2012
3Cysteine (L-Cysteine)FDA Link
01/2018 - 07/2017
3EnzymesIBA
09/2017 - 12/2006
33- hydroxy- 4- methoxy- beta- methyl- beta- nitrostyreneIBA
06/2017 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
12/2016 - 02/2011
3Benzo(a)pyreneIBA
03/2016 - 07/2011
34-boronic acid benzophenoneIBA
02/2016 - 04/2011
3phthalic acid (phthalate)IBA
02/2016 - 04/2011
3EstersIBA
02/2016 - 04/2011
3Parathyroid Hormone-Related ProteinIBA
05/2015 - 06/2013
3tricetinIBA
05/2015 - 09/2009
3shogaolIBA
02/2015 - 10/2009
3LactonesIBA
06/2010 - 05/2009
3SesquiterpenesIBA
06/2010 - 05/2009
3dehydrocostus lactoneIBA
06/2010 - 05/2009
3isoliquiritigenin (GU 17)IBA
07/2009 - 07/2004
3kotomolide AIBA
07/2008 - 11/2007
3plumbaginIBA
01/2008 - 08/2006
3ellipticineIBA
04/2006 - 06/2005
2LeptinIBA
07/2022 - 05/2022
2LipidsIBA
05/2022 - 06/2017
2Oxidoreductases (Dehydrogenase)IBA
09/2021 - 01/2017
2Messenger RNA (mRNA)IBA
09/2021 - 01/2021
2Cell Adhesion MoleculesIBA
06/2021 - 05/2019
2Tryptophan (L-Tryptophan)FDA Link
09/2020 - 05/2016
2DNA (Deoxyribonucleic Acid)IBA
02/2020 - 02/2011
2Cyclin AIBA
02/2020 - 06/2008
2Fatty Acids (Saturated Fatty Acids)IBA
11/2018 - 09/2017
2Nonesterified Fatty Acids (NEFA)IBA
11/2018 - 09/2017
2AllergensIBA
02/2018 - 05/2015
2Phytoestrogens (Phytoestrogen)IBA
01/2018 - 02/2014
2Angiopoietin-2IBA
01/2018 - 01/2017
2Acyl Coenzyme A (Acyl CoA)IBA
09/2017 - 06/2017
2laricitrinIBA
12/2016 - 03/2016
2Lysine (L-Lysine)FDA Link
05/2016 - 05/2012
2Hormones (Hormone)IBA
03/2016 - 05/2011
2didyminIBA
02/2016 - 06/2010
2Chemokine CCL5IBA
02/2016 - 05/2011
2GlycosidesIBA
02/2016 - 06/2010

Therapy/Procedure

6Immunotherapy
05/2022 - 02/2011
6Therapeutics
05/2022 - 05/2011
4Drug Therapy (Chemotherapy)
12/2015 - 06/2008
3Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2008 - 07/2004
2Renal Dialysis (Hemodialysis)
01/2020 - 01/2018
2Intraperitoneal Injections
03/2016 - 12/2010